Aseptix holds a large portfolio of patents and patent applications, which are globally granted. The portfolio now exceeds 80 patents on various platform technologies. The patenting strategy is both defensive as well as offensive and most patents are compositional patents, ensuring Aseptix to be the sole marketer of the compositions and avoiding any competition. The core technologies are well-protected against any competition or infringers and Aseptix follows an aggressive strategy against infringers and copiers, both for its own business, as well as on behalf of the license partners.